Synvista Therapeutics Inc SYNI
$0.00
Last Updated: Dec 30, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
Synvista Therapeutics Inc. Stock Analysis SYNI
United States Health Care Nano Cap Synvista Therapeutics, Inc. is a biotechnology company, which engages in the development of diagnostic tests and pharmaceutical drugs for the treatment of diabetes. The company is headquartered in Montvale, New Jersey and currently employs 9 full-time employees. The firm's lead drug candidate, alagebrium chloride or alagebrium, is an advanced glycation end-product crosslink breaker being developed for diastolic heart failure (DHF). Synvista is also managing a discovery and development program to produce small molecule drugs that mimic the enzyme glutathione peroxidase (GPx). One of the Company’s GPx mimetics, ALT-2074, is in Phase II clinical trials.
Synvista Therapeutics Inc (SYNI) Chart
Financial Metrics & Statements of Synvista Therapeutics Inc (SYNI)
FAQ's for Synvista Therapeutics Inc (SYNI)
- As of August 2026, Synvista Therapeutics Inc SYNI is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Synvista Therapeutics Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Synvista Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Synvista Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Synvista Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Synvista Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Synvista Therapeutics Inc (SYNI)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
